The effect of weight loss and exercise training on flow-mediated dilatation in coronary heart disease: A randomized trial

Chest

Volumn 140, Issue 6, 2011, Pages 1420-1427

  Ades, Philip A ^a   Savage, Patrick D ^a   Lischke, Stefan ^a   Toth, Michael J ^a   Harvey Berino, Jean ^a   Bunn, Janice Y ^a   Ludlow, Maryann ^a   Schneider, David J ^a  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID;

ABDOMINAL FAT; ADULT; AEROBIC EXERCISE; ARTICLE; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; ECHOGRAPHY; ENERGY EXPENDITURE; FEMALE; FITNESS; GLUCOSE METABOLISM; HEALTH BEHAVIOR; HEALTH PROGRAM; HUMAN; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; MALE; OBESITY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; WALKING; WEIGHT CHANGE; WEIGHT REDUCTION;

EID: 82955230678     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.10-3289     Document Type: Article

References (38)

1. Taylor RS, Brown A, Ebrahim S, et al. Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials. Am J Med. 2004;116(10):682-692. (Pubitemid 38581114)
2. Ades PA. Cardiac rehabilitation and secondary prevention of coronary heart disease. N Engl J Med. 2001;345(12):892-902.
3. Keteyian SJ, Brawner CA, Savage PD, et al. Peak aerobic capacity predicts prognosis in patients with coronary heart disease. Am Heart J. 2008;156(2):292-300.
4. Kavanagh T, Mertens DJ, Hamm LF, et al. Prediction of long-term prognosis in 12 169 men referred for cardiac rehabilitation. Circulation. 2002;106(6):666-671. (Pubitemid 34851924)
5. Kavanagh T, Mertens DJ, Hamm LF, et al. Peak oxygen intake and cardiac mortality in women referred for cardiac rehabilitation. J Am Coll Cardiol. 2003;42(12):2139-2143. (Pubitemid 37549899)
6. Ades PA, Savage PD, Brawner CA, et al. Aerobic capacity in patients entering cardiac rehabilitation. Circulation. 2006;113(23):2706-2712. (Pubitemid 43947988)
7. Audelin MC, Savage PD, Ades PA. Changing clinical profile of patients entering cardiac rehabilitation/secondary prevention programs: 1996 to 2006. J Cardiopulm Rehabil Prev.2008;28(5):299-306.
8. Savage PD, Banzer JA, Balady GJ, Ades PA. Prevalence of metabolic syndrome in cardiac rehabilitation/secondary prevention programs. Am Heart J. 2005;149(4):627-631.
9. Al Suwaidi J, Higano ST, Holmes DR Jr, Lennon R, Lerman A. Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol. 2001;37(6):1523-1528.
10. Schindler TH, Cardenas J, Prior JO, et al. Relationship between increasing body weight, insulin resistance, inflammation, adipocytokine leptin, and coronary circulatory function. J Am Coll Cardiol. 2006;47(6):1188-1195.
11. Prior JO, Quiñones MJ, Hernandez-Pampaloni M, et al. Coronary circulatory dysfunction in insulin resistance, impaired glucose tolerance, and type 2 diabetes mellitus. Circulation.2005;111(18):2291-2298. (Pubitemid 40647063)
12. Vogel RA. Cholesterol lowering and endothelial function. Am J Med. 1999;107(5):479-487. (Pubitemid 29528337)
13. Dupuis J, Tardif JC, Cernacek P, Théroux P. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes. The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial. Circulation.1999;99(25):3227- 3233.
14. Müller-Ehmsen J, Braun D, Schneider T, et al. Decreased number of circulating progenitor cells in obesity: beneficial effects of weight reduction. Eur Heart J. 2008;29(12): 1560-1568. (Pubitemid 351881989)
15. Gokce N, Vita JA, McDonnell M, et al. Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients. Am J Cardiol. 2005;95(2):266-268. (Pubitemid 40092098)
16. Schächinger V, Britten MB, Zeiher AM. Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation. 2000;101(16): 1899-1906. (Pubitemid 30225269)
17. Fichtlscherer S, Breuer S, Zeiher AM. Prognostic value of systemic endothelial dysfunction in patients with acute coronary syndromes: further evidence for the existence of the "vulnerable" patient. Circulation. 2004;110(14):1926-1932. (Pubitemid 39331903)
18. Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation. 2000;101(9):948-954. (Pubitemid 30131694)
19. Heitzer T, Schlinzig T, Krohn K, Meinertz T, Münzel T. Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease. Circulation. 2001;104(22):2673-2678. (Pubitemid 33108132)
20. Lavie CJ, Milani RV, Ventura HO. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol. 2009;53(21):1925-1932.
21. Fonarow GC. Clinical implications of the obesity para dox in patients with coronary artery disease. Am J Med. 2009; 122(12):1069.
22. Ades PA, Savage PD. The obesity paradox: perception vs knowledge. Mayo Clin Proc. 2010;85(2):112-114.
23. Ades PA, Savage PD, Toth MJ, et al. High-calorie-expenditure exercise: a new approach to cardiac rehabilitation for overweight coronary patients. Circulation. 2009;119(20):2671-2678.
24. Lavie CJ, Milani RV, Artham SM, Patel DA, Ventura HO. The obesity paradox, weight loss, and coronary disease. Am J Med.2009;122(12):1106-1114.
25. Artham SM, Lavie CJ, Milani RV, Ventura HO. Value of weight reduction in patients with cardiovascular disease. Curr Treat Options Cardiovasc Med. 2010;12(1):21-35.
26. Sierra-Johnson J, Romero-Corral A, Somers VK, et al. Prognostic importance of weight loss in patients with coronary heart disease regardless of initial body mass index. Eur J Cardiovasc Prev Rehabil. 2008;15(3):336-340.
27. Hambrecht R, Wolf A, Gielen S, et al. Effect of exercise on coronary endothelial function in patients with coronary artery disease. N Engl J Med. 2000;342(7):454-460. (Pubitemid 30100232)
28. Savage PD, Brochu M, Poehlman ET, Ades PA. Reduction in obesity and coronary risk factors after high caloric exercise training in overweight coronary patients. Am Heart J.2003;146(2):317-323. (Pubitemid 36951778)
29. Corretti MC, Anderson TJ, Benjamin EJ, et al. International Brachial Artery Reactivity Task Force. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 2002;39(2):257-265. (Pubitemid 34084631)
30. Smith SC Jr, Allen J, Blair SN, et al. AHA/ACC; National Heart, Lung, and Blood Institute. AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute. Circulation.2006;113(19):2363- 2372. (Pubitemid 43947981)
31. Harvey-Berino J. Weight loss in the clinical setting: applications for cardiac rehabilitation. Coron Artery Dis. 1998;9(12):795-798. (Pubitemid 29010180)
32. Ades PA, Savage PD, Harvey-Berino J. The treatment of obesity in cardiac rehabilitation. J Cardiopulm Rehabil Prev.2010;30(5):289-298.
33. Zeni AI, Hoffman MD, Clifford PS. Energy expenditure with indoor exercise machines. JAMA. 1996;275(18):1424-1427. (Pubitemid 26155918)
34. Toth MJ, Cooper BC, Pratley RE, Mari A, Matthews DE, Casson PR. Effect of ovarian suppression with gonadotropin-releasing hormone agonist on glucose disposal and insulin secretion. Am J Physiol Endocrinol Metab. 2008;294(6):E1035- E1045.
35. Schoeller DA. Recent advances from application of doubly labeled water to measurement of human energy expenditure. J Nutr. 1999;129(10):1765-1768. (Pubitemid 29468587)
36. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance . Am J Physiol. 1979;237(3):E214-E223. (Pubitemid 9249478)
37. Hamburg NM, Larson MG, Vita JA, et al. Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham Offspring participants without clinical evidence of cardiovascular disease. Am J Cardiol. 2008;101(1):82-88.
38. Gokce N, Vita JA, Bader DS, et al. Effect of exercise on upper and lower extremity endothelial function in patients with coronary artery disease. Am J Cardiol. 2002;90(2):124-127. (Pubitemid 34775119)